Business Context and Reporting Period
This Form 8-K Current Report was filed by Palisade Bio, Inc. on February 23, 2022, covering events reported as of February 16, 2022. The filing details executive compensation adjustments, including salary increases, bonus payments, and equity grants approved by the Board of Directors and the Compensation Committee.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on executive compensation figures:
- 2022 Base Salary Increases: CEO Thomas M. Hallam ($530,000), CFO J.D. Finley ($424,000), and CMO Michael Dawson ($240,000).
- 2021 Cash Bonus Awards: CEO Thomas M. Hallam ($159,000), CFO J.D. Finley ($104,000), and CMO Michael Dawson ($27,800).
- Equity Grants: Stock options granted to CEO (156,600 shares), CFO (64,800 shares), and CMO (32,400 shares).
Material Changes
The primary material change reported is the adjustment of executive compensation effective January 1, 2022, with the exception of Dr. Dawson's salary increase, which is contingent upon him dedicating 50% of his time to the Company. Additionally, the Company approved 2021 performance bonuses and new stock option grants under the 2021 Equity Incentive Plan.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business operations. It does not disclose specific risks or contingencies beyond the standard terms of the equity grants, which include vesting schedules and termination conditions.
Investor Verification Checklist
- Verify the effective date of Dr. Dawson's salary increase relative to his 50% time commitment.
- Confirm the exercise price per share for the newly granted stock options based on the Nasdaq closing price on February 17, 2022.
- Review the vesting schedule details (1/12th vesting after three months, followed by quarterly vesting over three years) for the granted options.
- Check subsequent filings for any changes to the 2021 Equity Incentive Plan or executive roles.